Cargando…

The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey

BACKGROUND: It is well established that the different antipsychotics used for schizophrenia symptoms differ substantially in their side effects. However, relatively little is known about the impact of these side effects on functioning from the patient’s perspective. We aimed to understand how key si...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandon, Rajiv, Lenderking, William R., Weiss, Catherine, Shalhoub, Huda, Barbosa, Carla Dias, Chen, Jun, Greene, Mallik, Meehan, Stine R., Duvold, Laëtitia Bouérat, Arango, Celso, Agid, Ofer, Castle, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359579/
https://www.ncbi.nlm.nih.gov/pubmed/32684942
http://dx.doi.org/10.1186/s12991-020-00292-5
_version_ 1783559078244515840
author Tandon, Rajiv
Lenderking, William R.
Weiss, Catherine
Shalhoub, Huda
Barbosa, Carla Dias
Chen, Jun
Greene, Mallik
Meehan, Stine R.
Duvold, Laëtitia Bouérat
Arango, Celso
Agid, Ofer
Castle, David
author_facet Tandon, Rajiv
Lenderking, William R.
Weiss, Catherine
Shalhoub, Huda
Barbosa, Carla Dias
Chen, Jun
Greene, Mallik
Meehan, Stine R.
Duvold, Laëtitia Bouérat
Arango, Celso
Agid, Ofer
Castle, David
author_sort Tandon, Rajiv
collection PubMed
description BACKGROUND: It is well established that the different antipsychotics used for schizophrenia symptoms differ substantially in their side effects. However, relatively little is known about the impact of these side effects on functioning from the patient’s perspective. We aimed to understand how key side effects of second-generation antipsychotics impact the functioning and quality of life (QoL) of patients with schizophrenia. METHODS: This is a cross-sectional, web-based survey of patient-reported side effect burden of antipsychotic drugs in adults with schizophrenia. The survey was deployed in the United States, Canada, Australia, Spain, Italy, Norway, and Denmark. It included sociodemographic and clinical questions, the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF), and the Glasgow Antipsychotic Side-Effect Scale (GASS). Eight pre-defined key side effects classified as activating (“Shaky hands or arms,” “Restlessness,” and “Difficulty sleeping”), sedating (“Sleepy during the day”, “Feeling drugged or like a zombie,” and “Feeling dizzy/Fainted”) or other side effects (“Problems enjoying sex” and “Gaining weight”), and additional questions related to impacts on function and quality of life were asked. RESULTS: In total, 435 participants (mean age: 38 years, 53.8% female) were included. The total Q-LES-Q-SF score indicated overall medium satisfaction with their quality of life (score of 44.3; possible range 14–70). The most prevalent side effects were “Sleepy during the day” (83.2%), “Difficulty sleeping” (74.7%), “Dry mouth” (63.9%), “Problems enjoying sex” (53.4%) and “Gaining weight” (52.4%). Women reported the side effects of “Sleepy during the day”, “Problems enjoying sex” and “Gaining weight” more frequently than men. Key side effects impacted physical, social, occupational and psychological aspects of functioning. Patients with key side effects often felt frustrated by their experiences. Total Q-LES-Q-SF score showed a significant inverse correlation with the score of pre-defined groups of side effects indicating worse QoL in association with more severe key side effects in these patients. CONCLUSION: Stable patients with schizophrenia taking second-generation antipsychotics live with many side effects, including activating and sedating side effects, sexual side effects, and weight gain. Presence of these side effects is associated with substantial impacts across all aspects of daily functioning and lower quality of life and satisfaction.
format Online
Article
Text
id pubmed-7359579
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73595792020-07-17 The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey Tandon, Rajiv Lenderking, William R. Weiss, Catherine Shalhoub, Huda Barbosa, Carla Dias Chen, Jun Greene, Mallik Meehan, Stine R. Duvold, Laëtitia Bouérat Arango, Celso Agid, Ofer Castle, David Ann Gen Psychiatry Primary Research BACKGROUND: It is well established that the different antipsychotics used for schizophrenia symptoms differ substantially in their side effects. However, relatively little is known about the impact of these side effects on functioning from the patient’s perspective. We aimed to understand how key side effects of second-generation antipsychotics impact the functioning and quality of life (QoL) of patients with schizophrenia. METHODS: This is a cross-sectional, web-based survey of patient-reported side effect burden of antipsychotic drugs in adults with schizophrenia. The survey was deployed in the United States, Canada, Australia, Spain, Italy, Norway, and Denmark. It included sociodemographic and clinical questions, the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF), and the Glasgow Antipsychotic Side-Effect Scale (GASS). Eight pre-defined key side effects classified as activating (“Shaky hands or arms,” “Restlessness,” and “Difficulty sleeping”), sedating (“Sleepy during the day”, “Feeling drugged or like a zombie,” and “Feeling dizzy/Fainted”) or other side effects (“Problems enjoying sex” and “Gaining weight”), and additional questions related to impacts on function and quality of life were asked. RESULTS: In total, 435 participants (mean age: 38 years, 53.8% female) were included. The total Q-LES-Q-SF score indicated overall medium satisfaction with their quality of life (score of 44.3; possible range 14–70). The most prevalent side effects were “Sleepy during the day” (83.2%), “Difficulty sleeping” (74.7%), “Dry mouth” (63.9%), “Problems enjoying sex” (53.4%) and “Gaining weight” (52.4%). Women reported the side effects of “Sleepy during the day”, “Problems enjoying sex” and “Gaining weight” more frequently than men. Key side effects impacted physical, social, occupational and psychological aspects of functioning. Patients with key side effects often felt frustrated by their experiences. Total Q-LES-Q-SF score showed a significant inverse correlation with the score of pre-defined groups of side effects indicating worse QoL in association with more severe key side effects in these patients. CONCLUSION: Stable patients with schizophrenia taking second-generation antipsychotics live with many side effects, including activating and sedating side effects, sexual side effects, and weight gain. Presence of these side effects is associated with substantial impacts across all aspects of daily functioning and lower quality of life and satisfaction. BioMed Central 2020-07-13 /pmc/articles/PMC7359579/ /pubmed/32684942 http://dx.doi.org/10.1186/s12991-020-00292-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Tandon, Rajiv
Lenderking, William R.
Weiss, Catherine
Shalhoub, Huda
Barbosa, Carla Dias
Chen, Jun
Greene, Mallik
Meehan, Stine R.
Duvold, Laëtitia Bouérat
Arango, Celso
Agid, Ofer
Castle, David
The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
title The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
title_full The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
title_fullStr The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
title_full_unstemmed The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
title_short The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
title_sort impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359579/
https://www.ncbi.nlm.nih.gov/pubmed/32684942
http://dx.doi.org/10.1186/s12991-020-00292-5
work_keys_str_mv AT tandonrajiv theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT lenderkingwilliamr theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT weisscatherine theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT shalhoubhuda theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT barbosacarladias theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT chenjun theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT greenemallik theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT meehanstiner theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT duvoldlaetitiabouerat theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT arangocelso theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT agidofer theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT castledavid theimpactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT tandonrajiv impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT lenderkingwilliamr impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT weisscatherine impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT shalhoubhuda impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT barbosacarladias impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT chenjun impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT greenemallik impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT meehanstiner impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT duvoldlaetitiabouerat impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT arangocelso impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT agidofer impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey
AT castledavid impactonfunctioningofsecondgenerationantipsychoticmedicationsideeffectsforpatientswithschizophreniaaworldwidecrosssectionalwebbasedsurvey